Growth at a reasonable price screen

Growth at a reasonable price sits between value and growth investing: it looks for companies whose earnings are growing, but that the market has not yet priced as growth stocks. Peter Lynch made its best-known yardstick popular, the PEG ratio — the P/E divided by the expected growth rate — reckoning that a fairly priced company has a PEG of about one and a bargain less.

This screen asks for a trailing P/E below 15, a PEG below 1, analysts' expected earnings growth above 10% a year over the next five years, revenue growth above 5% over the last twelve months, and less debt than equity. The expected growth is the analysts' consensus, and forecasts are often wrong, so the screen finds companies that are cheap if the forecasts hold. The companies are ordered by PEG, lowest first.

The rules

P/E positive, up to 15.0×
PEG positive, up to 1.0×
EPS growth, next 5Y above 10.0%
Revenue growth above 5.00%
Debt/equity below 1.0×

200 companies match today

Open in screener
Ticker Company Sector PEG P/E EPS growth, next 5Y Revenue growth Market cap
IRWD Ironwood Pharmaceuticals, Inc. Healthcare 0.03 5.18 112.04% 26.19% 692.36m
AGEN Agenus Inc. Healthcare 0.03 3.23 37.45% 30.47% 375.30m
CENX Century Aluminum Company Basic Materials 0.04 6.28 84.66% 9.67% 3.77b
PICS PicS N.V. 0.04 0.01 69.02% 98.18% 1.15b
WDH Waterdrop Inc. Unsponsored ADR Financial 0.05 4.95 111.86% 80.88% 286.30m
DAN Dana Incorporated Consumer Cyclical 0.05 2.70 135.26% 14.91% 2.93b
GAU Galiano Gold Inc. Basic Materials 0.05 7.36 51.65% 122.15% 523.18m
SRTA Strata Critical Medical, Inc. Healthcare 0.08 10.51 55.32% 136.11% 476.84m
MUX McEwen Inc. Basic Materials 0.09 13.88 84.26% 47.73% 1.14b
CAL Caleres, Inc. Consumer Cyclical 0.09 8.29 66.37% 7.32% 430.97m

Showing 10 of 200. A free account shows 25 · Powerpack shows all 200, with Excel export and email when the list changes.

Email me when this changes Powerpack

Updated 26 September 2026.